BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19466969)

  • 1. Enterovirus infection of neuronal cells post-Rituximab.
    Kiani-Alikhan S; Skoulidis F; Barroso A; Nuovo G; Ushiro-Lumb I; Breuer J; Lister A; Mattes F
    Br J Haematol; 2009 Aug; 146(3):333-5. PubMed ID: 19466969
    [No Abstract]   [Full Text] [Related]  

  • 2. Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma.
    Servais S; Caers J; Warling O; Frusch N; Baron F; De Prijck B; Beguin Y
    Br J Haematol; 2010 Aug; 150(3):379-81. PubMed ID: 20408837
    [No Abstract]   [Full Text] [Related]  

  • 3. Opportunistic enteroviral meningoencephalitis: an unusual treatable complication of rituximab therapy.
    Ganjoo KN; Raman R; Sobel RA; Pinto HA
    Leuk Lymphoma; 2009 Apr; 50(4):673-5. PubMed ID: 19373672
    [No Abstract]   [Full Text] [Related]  

  • 4. Enterovirus 71 meningoencephalitis complicating rituximab therapy.
    Ahmed R; Buckland M; Davies L; Halmagyi GM; Rogers SL; Oberste S; Barnett MH
    J Neurol Sci; 2011 Jun; 305(1-2):149-51. PubMed ID: 21444094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.
    Quartier P; Tournilhac O; Archimbaud C; Lazaro L; Chaleteix C; Millet P; Peigue-Lafeuille H; Blanche S; Fischer A; Casanova JL; Travade P; Tardieu M
    Clin Infect Dis; 2003 Feb; 36(3):e47-9. PubMed ID: 12539090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal central nervous system lesions emerging during anti-CD20 monoclonal antibody therapy (Rituximab) for a post transplantation Epstein Barr virus-linked lymphoma.
    Sirvent-Von Bueltzingsloewen A; Sirvent N; Morand P; Cassuto JP
    Med Pediatr Oncol; 2003 Jun; 40(6):408-9. PubMed ID: 12692818
    [No Abstract]   [Full Text] [Related]  

  • 7. Fulminant hepatitis B following rituximab therapy in a patient with Evans syndrome and large B-cell lymphoma.
    Ozgönenel B; Moonka D; Savaşan S
    Am J Hematol; 2006 Apr; 81(4):302. PubMed ID: 16550511
    [No Abstract]   [Full Text] [Related]  

  • 8. Can rituximab change the usually dismal prognosis of patients with intravascular large B-cell lymphoma?
    Ferreri AJ; Dognini GP; Govi S; Crocchiolo R; Bouzani M; Bollinger CR; D'Incan M; Delaporte E; Hamadani M; Jardin F; Martusewicz-Boros M; Montanari M; Szomor A; Zucca E; Cavalli F; Ponzoni M
    J Clin Oncol; 2008 Nov; 26(31):5134-6; author reply 5136-7. PubMed ID: 18838697
    [No Abstract]   [Full Text] [Related]  

  • 9. Rituximab in diffuse large B-cell lymphoma.
    Coiffier B
    Clin Adv Hematol Oncol; 2004 Mar; 2(3):156-7. PubMed ID: 16166943
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-barr virus-positive diffuse large B-cell lymphoma during therapy with alemtuzumab for T-cell prolymphocytic leukemia.
    Sohani AR; Ferry JA; Chang PS; Abramson JS
    J Clin Oncol; 2010 Feb; 28(5):e69-72. PubMed ID: 19917859
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytomegalovirus gastritis after treatment with rituximab.
    Hasegawa Y; Goto A; Nishimura S; Sukawa Y; Fujii K; Suzuki K; Yonezawa K; Abe T; Shinomura Y; Yoshida Y
    Endoscopy; 2009; 41 Suppl 2():E199. PubMed ID: 19637127
    [No Abstract]   [Full Text] [Related]  

  • 12. An imaging-based rapid evaluation method for complement-dependent cytotoxicity discriminated clinical response to rituximab-containing chemotherapy.
    Mishima Y; Sugimura N; Matsumoto-Mishima Y; Terui Y; Takeuchi K; Asai S; Ennishi D; Asai H; Yokoyama M; Kojima K; Hatake K
    Clin Cancer Res; 2009 May; 15(10):3624-32. PubMed ID: 19417028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab.
    Steurer M; Clausen J; Gotwald T; Gunsilius E; Stockhammer G; Gastl G; Nachbaur D
    Transplantation; 2003 Jul; 76(2):435-6. PubMed ID: 12883208
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravascular large B-cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy.
    Horváth B; Demeter J; Eros N; Hársing J; Csomor J; Matolcsy A; Bottlik G; Gyori G; Marschalkó M; Kárpáti S
    J Am Acad Dermatol; 2009 Nov; 61(5):885-8. PubMed ID: 19632742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reactivation of hepatitis B after treatment with CHOP and rituximab].
    Fernández Fernández FJ; de la Fuente Aguado J; Puerta Louro R; Fernández Villaverde A; Soto Ríos C
    Rev Clin Esp; 2007 Apr; 207(4):220. PubMed ID: 17475194
    [No Abstract]   [Full Text] [Related]  

  • 16. Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma.
    Lai GG; Lim ST; Tao M; Chan A; Li H; Quek R
    Am J Hematol; 2009 Jul; 84(7):414-7. PubMed ID: 19415727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteroviral encephalitis in a patient with a marginal zone lymphomatreated with rituximab.
    Schilthuizen C; Berenschot HW; Levin MD
    Neth J Med; 2010 May; 68(5):221-3. PubMed ID: 20508271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
    Grange F; Maubec E; Bagot M; Beylot-Barry M; Joly P; Dalle S; Delaporte E; Dereure O; Bachelez H; Vergier B; Petrella T; D'Incan M
    Arch Dermatol; 2009 Mar; 145(3):329-30. PubMed ID: 19289772
    [No Abstract]   [Full Text] [Related]  

  • 19. Neutropenic fever following chemotherapy in a patient with lymphoma.
    Book L
    Oncol Nurs Forum; 2008 Nov; 35(6):885-7. PubMed ID: 18980919
    [No Abstract]   [Full Text] [Related]  

  • 20. Rituximab and chemotherapy in diffuse large B-cell lymphoma.
    Sonet A; Bosly A
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):719-26. PubMed ID: 19496708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.